Many HIV service organizations need to grow and change, and that means becoming more reflective of the communities they serve, from bottom to top. Here's some advice on how to get there.
We spoke with Amy Killelea at NASTAD, a major national health policy advocacy organization, about the priorities she sees in January 2021 and beyond.
HIV infection rates among Black women in the U.S. have fallen sharply over the past decade, but look closer and the numbers still paint a troubling story.
Already dealing with legal pushbacks, harm-reduction advocates for safe drug consumption sites now have COVID-19 to blame for slow progress.
These HIV Experts Engage Black and Brown Folks on the COVID-19 Vaccine Trials Despite Medical Mistrust
Trump’s “Operation Warp Speed” has left people of color even more wary about research, they say. But it’s still possible, if done the right way by the right people.
This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect
Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.
When will academic institutions educate on where health disparities come from?
These doctors have found strategies to address misinformation on the web by speaking directly to concerned audiences.
Natalia Linos, Sc.D., M.Sc., of Harvard University’s FXB Center for Health and Human Rights, calls for protections for low-wage essential workers and releasing people from jails, prisons, and ICE detention.
A Longtime HIV/LGBTQ Doctor Volunteered in a New York City Public Hospital Against COVID-19. Here’s What He Learned.
“It was like you were in the Lifetime movie version of a hospital,” Mayer said.
Dr. Melanie Thompson discusses what’s happening in the state around coronavirus, and what it means for people living with HIV.